Research and optimization of the treatment of advanced gastric cancer with Chinese and Western medicine based on TCM tumor registration platform
- Conditions
- Advanced gastric cancer
- Registration Number
- ITMCTR2000003907
- Lead Sponsor
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients with gastric cancer diagnosed pathologically;
2. Patients with TNM stage ?;
3. Patients with age = 18 years old, regardless of gender;
4. Patients with Karnofsky score = 60;
5. Patients who have been or will receive systematic Chinese medicine treatment (oral treatment of syndrome differentiation and treatment Decoction at the TCM oncologist's office);
6. Patients who voluntarily accept the study and sign the informed consent form can cooperate with the follow-up once every 2 months, about 6 times, and cooperate to improve the current treatment measures and relevant information.
1. Patients with two or more primary malignant tumors;
2. Patients with serious non neoplastic diseases and dysfunction, active cerebrovascular diseases, uncontrolled infection and metabolic diseases, neuropsychiatric diseases, cognitive dysfunction and other important organs such as heart, lung, liver, kidney, etc;
3. Patients can not or refuse to take oral medicine;
4. The patients whose expected survival time is less than 3 months;
5. Other situations that the researcher thinks are not suitable to participate in this clinical study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival;progression-free survival;
- Secondary Outcome Measures
Name Time Method Response Evaluation Criteria in Solid Tumors;Karnofsky Performance Scale;EORTC QLQ-C30 (V3.0) and QLQ-STO22 score;MD Anderson Symptom Inventory;